Artiva CEO Aslan sells 23,463 shares
Artiva Biotherapeutics CEO Fred Aslan reported a sale of 23,463 shares at $7.20 each, for $168,880, in a Form 4 filing. The filing says the transaction was made under a 10b5-1 plan.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.